Low density lipoprotein-containing circulating immune complexes have better prognostic value in carotid intima-media thickness progression than other lipid parameters.
Association of the level of heteroplasmy of the 15059G>A mutation in the MT-CYB mitochondrial gene with essential hypertension.
Changes in levels of gene expression in human aortal intima during atherogenesis.
Changes of lysosomes in the earliest stages of the development of atherosclerosis.
Anti-atherosclerotic therapy based on botanicals.
Changes of mitochondria in atherosclerosis: possible determinant in the pathogenesis of the disease.
Dendritic cells: A double-edge sword in atherosclerotic inflammation.
Regulatory T cells in atherosclerosis and strategies to induce the endogenous atheroprotective immune response.
Diagnostic and prognostic value of low density lipoprotein-containing circulating immune complexes in atherosclerosis.
[Interaction of native and modified low density lipoprotein with intimal cells in atherosclerotic lesion].
Association of mitochondrial genetic variation with carotid atherosclerosis.
Blood Atherogenicity as a Target for Anti-atherosclerotic Therapy.
Cyclophilins in atherosclerosis: a new therapeutic target?
Direct anti-atherosclerotic therapy; development of natural anti-atherosclerotic drugs preventing cellular cholesterol retention.
Importance of Receptor-targeted Systems in the Battle Against Atherosclerosis.
Increased shedding of microvesicles from intimal smooth muscle cells in athero-prone areas of the human aorta: implications for understanding of the predisease stage.
Lipid regulators during atherogenesis: expression of LXR, PPAR, and SREBP mRNA in the human aorta.
Mitochondrial mutations in atherosclerosis: new solutions in research and possible clinical applications.
Novel monocyte biomarkers of atherogenic conditions.
Strategies to deliver microRNAs as potential therapeutics in the treatment of cardiovascular pathology.
Pluronic block copolymers inhibit low density lipoprotein self-association.
Mitochondrial dysfunction and mitochondrial DNA mutations in atherosclerotic complications in diabetes.
Monocytes as a diagnostic marker of cardiovascular diseases.
Widespread distribution of HLA-DR-expressing cells in macroscopically undiseased intima of the human aorta: a possible role in surveillance and maintenance of vascular homeostasis.
[Cholesterol of circulating immune complexes as biomarker of atherosclerosis].
[Cultured cell systems for revelation of new drugs antiatherosclerotic effects and their mechanisms investigation].
[Dendritic cells and their role in immune reactions of atherosclerosis].
[Study of intima-medial thickness (IMT) of the carotid arteries as an indicator of natural atherosclerosis progress in Moscow population].
Mitochondrial mutations are associated with atherosclerotic lesions in the human aorta.
Mutation C3256T of mitochondrial genome in white blood cells: novel genetic marker of atherosclerosis and coronary heart disease.
Correlation between lipid deposition, immune-inflammatory cell content and MHC class II expression in diffuse intimal thickening of the human aorta.
Contents of mRNAs encoding endosome/lysosome components in normal human aorta and in stage II of atherogenesis: a hidden regulation.
Musashi-1 expression in atherosclerotic arteries and its relevance to the origin of arterial smooth muscle cells: histopathological findings and speculations.
[A new method of quantitative estimation of mutant allele in mitochondrial genome].
[Numbers of cells and cell proliferation in intima of different human arteries].
[Variability of intima-media thickness of the common carotid arteries in Moscow city population without clinical symptoms of atherosclerosis].
Decreased expression of liver X receptor-α in macrophages infected with Chlamydia pneumoniae in human atherosclerotic arteries in situ.
The interaction of plasma sialylated and desialylated lipoproteins with collagen from the intima and media of uninvolved and atherosclerotic human aorta.
Peculiarities of cell composition and cell proliferation in different type atherosclerotic lesions in carotid and coronary arteries.
The effects of time-released garlic powder tablets on multifunctional cardiovascular risk in patients with coronary artery disease.
Time-released garlic powder tablets lower systolic and diastolic blood pressure in men with mild and moderate arterial hypertension.
Studies of the human aortic intima by a direct quantitative assay of mutant alleles in the mitochondrial genome.
Deglycosylation of apo B-containing lipoproteins increase their ability to aggregate and to promote intracellular cholesterol accumulation in vitro.
Lipid-lowering effects of time-released garlic powder tablets in double-blinded placebo-controlled randomized study.
Comparative contents of mRNAs of sex steroid receptors and enzymes of their metabolism in arterial walls of men.
Metabolic effects of time-released garlic powder tablets in type 2 diabetes mellitus: the results of double-blinded placebo-controlled study.
Use of natural products in anticytokine therapy.
Oxidation-induced aggregation of LDL increases their uptake by smooth muscle cells from human aorta.
[Use of allicor to lower the risk of myocardial infarction]
Antiatherogenic effect of grape flavonoids in an ex vivo model.
Proteolysis of apoprotein B-100 impairs its topography on LDL surface and reduces LDL association resistance.
Phospholipid hydrolysis with phospholipases A2 and C impairs apolipoprotein B-100 conformation on the surface of low density lipoproteins by reducing their association resistance.
Desialylation decreases the resistance of apo B-containing lipoproteins to aggregation and increases their atherogenic potential.
[A comparative study of the lipid phase in native and circulating multiple-modified low-density lipoproteins of human blood by the use of the spin probe method]
[Allicor efficacy in lowering the risk of ischemic heart disease in primary prophylaxis]
[Low-density lipoproteins with different capacity for aggregation]
[Reduction of cardiovascular risk in primary prophylaxy of coronary heart disease]
Resistance of native and circulating modified low-density lipoproteins in human blood to association.
Low ionic strength promotes association of circulating modified LDL in human blood.
Antigenic differences between apo-B in native and circulating modified low-density lipoproteins.
[Study of an antioxidant dietary supplement "Karinat" in patients with benign breast disease]
[Study of the antioxidant drug "Karinat" in patients with chronic atrophic gastritis]
Human plasma trans-sialidase donor and acceptor specificity.
[Hypotensive effect of long-acting garlic tablets allicor (a double-blind placebo-controlled trial)]
Human plasma trans-sialidase causes atherogenic modification of low density lipoprotein.
The content of lipoperoxidation products in normal and atherosclerotic human aorta.
[Use of allikor for the normalization of fibrinolysis and hemostasis in patients with chronic cerebrovascular diseases]
Evaluation of cell proliferation in human atherosclerotic lesions.
[Interactions of low density lipoproteins with elastin in the intima and media from the intact and atherosclerotic human aorta]
Are all low-density lipoprotein particles partially desialylated in plasma?
[The identification of pericyte-like cells in the subendothelium of human blood vessels]
Optimization of the assay for sialic acid determination in low density lipoprotein.
Antioxidant content in low density lipoprotein and lipoprotein oxidation in vivo and in vitro.
Cell proliferation in normal and atherosclerotic human aorta: proliferative splash in lipid-rich lesions.
In vivo oxidized low density lipoprotein: degree of lipoprotein oxidation does not correlate with its atherogenic properties.
Low-density lipoprotein modification occurring in human plasma possible mechanism of in vivo lipoprotein desialylation as a primary step of atherogenic modification.
Continuous subendothelial network formed by pericyte-like cells in human vascular bed.
[New prospects for the treatment of atherosclerosis: garlic preparations]
The effects of antihypertensive agents on atherosclerosis-related parameters of human aorta intimal cells.
Antiatherosclerotic and antiatherogenic effects of a calcium antagonist plus statin combination: amlodipine and lovastatin.
Subendothelial smooth muscle cells of human aorta express macrophage antigen in situ and in vitro.
In vitro effect of garlic powder extract on lipid content in normal and atherosclerotic human aortic cells.
[Effect of the garlic tablets allicor on thrombocyte aggregation in vitro and ex vivo]
Collagen-synthesizing cells in initial and advanced atherosclerotic lesions of human aorta.
[Localization of collagen-synthesizing cells in normal and atherosclerotic intima of human aorta]
Effects of garlic on atherosclerosis.
Lack of correlation between degree of human plasma low density lipoprotein oxidation and its atherogenic potential.
Metabolism of native and naturally occurring multiple modified low density lipoprotein in smooth muscle cells of human aortic intima.
Similarity between naturally occurring modified desialylated, electronegative and aortic low density lipoprotein.
[Lipid composition of polymodified (desialylated) low density lipoproteins]
Atherogenic modified LDL in diabetes.
[Direct antiatherogenic effect of garlic]
Characteristics of low density lipoprotein isolated from circulating immune complexes.
[Multiply-modified disialyated low-density lipoproteins: physico-chemical properties]
[Intercellular communication studied by using the gap junctions in a primary cell culture of human aortic intima]
Diagnostic value of immune cholesterol as a marker for atherosclerosis.
Gap junctional communication in primary culture of cells derived from human aortic intima.
Apolipoprotein B-bound lipids as a marker for evaluation of low density lipoprotein oxidation in vivo.
[Immunocytochemical study to localize a scavenger receptor in human aorta smooth muscle cells]
[Multiple modifications of low density lipoproteins in blood of patients with atherosclerosis]
[Protein-bound lipids in human low density lipoproteins]
Modified (desialylated) low-density lipoprotein measured in serum by lectin-sorbent assay.
Naturally occurring modified low density lipoproteins are similar if not identical: more electronegative and desialylated lipoprotein subfractions.
[Decrease in atherogenicity of blood serum in vitro under the effect of polyunsaturated phosphatidylcholine micelles].
Direct anti-atherosclerosis-related effects of garlic.
Heterogeneity of smooth muscle cells in embryonic human aorta.
Trihydroxyoctadecadienoic acids exhibit antiatherosclerotic and antiatherogenic activity.
Characterization of chemical composition of native and modified low density lipoprotein occurring in the blood of diabetic patients.
Sulfonylureas induce cholesterol accumulation in cultured human intimal cells and macrophages.
Effect of lipoprotein(a) on lipid metabolism of cultured human intimal aortic cells.
[Atherogenic effect of sugar-reducing drugs of the sulfonylurea group and its elimination using papaverine chloride]
[Atherogenic properties of oral sugar-reducing sulfonylurea derivatives]
Autoantibodies against low-density lipoprotein and atherogenic potential of blood.
Characteristics of low-density lipoprotein subfractions from patients with coronary artery disease.
Modified low density lipoprotein from diabetic patients causes cholesterol accumulation in human intimal aortic cells.
Carbohydrate composition of protein and lipid components in sialic acid-rich and -poor low density lipoproteins from subjects with and without coronary artery disease.
[Atherogenic potential of blood serum in patients with type I diabetes mellitus]
[Atherogenic properties of blood serum in children with type I diabetes mellitus]
[Effect of squid liver fat and krill meat on blood serum atherogenicity in patients with type I diabetes mellitus]
[The antiatherosclerotic effect of verapamil in a cell culture of human aortic intima]
[The effect of calcium antagonists on cholesterol metabolism in human aortal intima cells and macrophage lines]
Multiple-modified desialylated low density lipoproteins that cause intracellular lipid accumulation. Isolation, fractionation and characterization.
[Carbohydrate composition of native and desialylated low density lipoproteins in the plasma of patients with coronary atherosclerosis]
Lipid-laden white blood cells in the circulation of patients with coronary heart disease.
Beta-blockers: propranolol, metoprolol, atenolol, pindolol, alprenolol and timolol, manifest atherogenicity on in vitro, ex vivo and in vivo models. Elimination of propranolol atherogenic effects by papaverine.
Three types of naturally occurring modified lipoproteins induce intracellular lipid accumulation due to lipoprotein aggregation.
[Atherogenic properties of phenothiazine drugs manifesting in cultured cells of the human aortic intima]
[Effects of lovastatin therapy on the level of low density lipoproteins and atherogenic potential of serum in patients with ischemic heart disease and hypercholesterolemia]
Sialic acid content of human low density lipoproteins affects their interaction with cell receptors and intracellular lipid accumulation.
The atherogenic effect of lupus sera: systemic lupus erythematosus-derived immune complexes stimulate the accumulation of cholesterol in cultured smooth muscle cells from human aorta.
[The structure of the endothelialized and nonendothelialized areas of myointimal thickening of the rabbit aorta].
Three types of naturally occurring modified lipoproteins induce intracellular lipid accumulation in human aortic intimal cells--the role of lipoprotein aggregation.
[Elimination of the atherogenic effect of beta blocker propranolol by papaverine]
[Comparison between seasonal changes in lipid indicators in patients with post-infarction cardiosclerosis and arterial hypertension in Ashkhabad and Moscow]
Characterization of desialylated low-density lipoproteins which cause intracellular lipid accumulation.
Influence of a cholesterol rich diet in rabbits on the formation of PGI2 and TXA2.
Stellate cells of aortic intima: I. Human and rabbit.
Stellate cells of aortic intima: II. Arborization of intimal cells in culture.
Use of cell culture for optimisation of direct antiatherogenic therapy with verapamil.
[Atherogenic properties of sera and low-density lipoproteins in patients with diabetes mellitus]
[Seasonal variations of the lipid spectrum in patients with post-infarction cardiosclerosis and arterial hypertension]
Use of cultured atherosclerotic cells for investigation of antiatherosclerotic effects of anipamil and other calcium antagonists.
[Combined effects of desialylated and glycosylated low density lipoproteins on lipid content of human aortic intima cells in vitro]
Synergetic effect of desialylated and glycated low density lipoproteins on cholesterol accumulation in cultured smooth muscle intimal cells.
[Atherogenic effect of beta-blocker propranolol revealed in the rabbit denudated aorta]
Three-dimensional cytoarchitecture of normal and atherosclerotic intima of human aorta.
[Circulating immune complex cholesterol as a biochemical marker of coronary atherosclerosis]
[Relations between the levels of lipoprotein-containing immune complexes and lipids in the blood of patients with ischemic heart disease]
[The cellular polymorphism of the myointimal thickening in the rabbit aorta].
Desialylated low density lipoprotein--naturally occurring modified lipoprotein with atherogenic potency.
Lipids in cells of atherosclerotic and uninvolved human aorta. III. Lipid distribution in intimal sublayers.
Atherogenicity of autoantibodies against low density lipoprotein.
Use of human atherosclerotic cells for optimization of antiatherosclerotic therapy.
[Changes in the 3-dimensional organization of the cellular system of the human aortic intima in atherosclerosis]
[Structure of the neointima after balloon catheter injury of the rabbit aorta in the context of hypercholesterolemia: analysis of endothelial influence on lipid accumulation].
[The cholesterol content in immune complexes as a marker of coronary and peripheral atherosclerosis]
Antibody-like immunoglobulins G against low density lipoprotein that stimulate lipid accumulation in cultured cells.
Autoantibodies against modified low density lipoprotein. Nonlipid factor of blood plasma that stimulates foam cell formation.
Cholesterol level in circulating immune complexes as a marker of coronary atherosclerosis.
Lipoprotein immune complexes as markers of atherosclerosis.
Quantitative estimation of lipid-laden cells in atherosclerotic lesions of the human aorta.
[Isolation of desialylated low density lipoproteins from the blood of patients with ischemic heart disease by affinity chromatography]
In vitro models of anti-atherosclerotic effects of cardiovascular drugs.
[Blood lipophages in patients with ischemic heart disease]
[Desialylated low density lipoproteins--atherogenic lipoproteins occurring in blood of patients with coronary atherosclerosis]
[Aggregates of modified low density lipoproteins indicate accumulation of lipids in human aortic intima cells in vitro]
Low density lipoprotein-containing circulating immune complexes and coronary atherosclerosis.
[Effects of beta adrenergic blocking agents and calcium antagonists on atherogenic properties of blood serum of patients with ischemic heart disease]
Antiatherosclerotic effects of calcium antagonists. Study in human aortic cell culture.
Correlation between cholesterol content in circulating immune complexes and atherogenic properties of CHD patients' serum manifested in cell culture.
Isolation of atherogenic modified (desialylated) low density lipoprotein from blood of atherosclerotic patients: separation from native lipoprotein by affinity chromatography.
[Low density lipoproteins isolated from the blood of patients with ischemic heart disease induce accumulation of lipids in human aortic intima cells]
Local prevention of thrombosis in animal arteries by means of magnetic targeting of aspirin-loaded red cells.
Triggerlike stimulation of cholesterol accumulation and DNA and extracellular matrix synthesis induced by atherogenic serum or low density lipoprotein in cultured cells.
[Incidence among men of atherogenic potential of the serum detected in a culture of mouse peritoneal macrophages]
[Peritoneal macrophages as a model for the study of the atherogenic potential of the blood serum]
[The use of freeze fracturing in combination with light, scanning and transmission electron microscopy for studying the structure of the normal and atherosclerotically altered human aortic intima]
Peritoneal macrophages: a model for detecting atherogenic potential in patients' blood serum.
Insolubilization of low density lipoprotein induces cholesterol accumulation in cultured subendothelial cells of human aorta.
[Cholesterol-containing circulating immune complexes--a component of the blood serum in patients with ischemic heart disease that determines its atherogenic properties]
Lipoprotein aggregation as an essential condition of intracellular lipid accumulation caused by modified low density lipoproteins.
Ganglioside content and composition of cells from normal and atherosclerotic human aorta.
Modification of low density lipoprotein by desialylation causes lipid accumulation in cultured cells: discovery of desialylated lipoprotein with altered cellular metabolism in the blood of atherosclerotic patients.
[Atherogenic properties of beta adrenergic blockaders evident on vascular wall cells]
Low-density lipoproteins isolated from the blood of patients with coronary heart disease induce the accumulation of lipids in human aortic cells.
[Effect of medicinal leech preparations on indicators of atherogenesis]
[The content of cyclic nucleotides in an organ culture of normal and atherosclerosis-affected human aorta]
Neutral glycolipids of atherosclerotic plaques and unaffected human aorta tissue.
Use of lipophilic fluorescent probes for the isolation of hybrid cells in flow cytometry.
[Anti-atherosclerotic properties of eicosapentaenoic acid: clinico-experimental study]
[Lysosomal proteinases of the human aortal intima and atherogenesis]
[The effect of eicosapentaenoic acid and various prostaglandins on cholesterol accumulation and proliferation of intima cells from human aorta]
[The effect of glucagon and concanavalin A on cholesterol accumulation in mouse peritoneal macrophages and human aorta intima cells]
Modulation of human aorta smooth muscle cell phenotype: a study of muscle-specific variants of vinculin, caldesmon, and actin expression.
Stable analogues of prostacyclin and thromboxane A2 display contradictory influences on atherosclerotic properties of cells cultured from human aorta. The effect of calcium antagonists.
Atherogenic effects of beta blockers on cells cultured from normal and atherosclerotic aorta.
Blood serum atherogenicity associated with coronary atherosclerosis. Evidence for nonlipid factor providing atherogenicity of low-density lipoproteins and an approach to its elimination.
[Effect of lipostabil on cholesterol levels in atherosclerotic plaques of the human aorta and the aggregative capacity of thrombocytes (in vitro study)]
Cardiovascular drugs and atherosclerosis: effects of calcium antagonists, beta-blockers, and nitrates on atherosclerotic characteristics of human aortic cells.
Intracellular cholesterol accumulation is accompanied by enhanced proliferative activity of human aortic intimal cells.
Prostacyclin, thromboxane A2 and calcium antagonists: effects on atherosclerotic characteristics of vascular cells.
The effects of eicozanoids and lipoxygenase inhibitors on the lipid metabolism of aortic cells.
Cyclic nucleotides and atherosclerosis: studies in primary culture of human aortic cells.
Spontaneous atherosclerotic plaque and obstruction of distal anastomosis in femoral artery. Comparative morphologic study.
[Decreased lipid levels in arteriosclerotic plaques of the human aorta after LDL-apheresis (an in vitro study)]
[Effect of components of the extracellular matrix on the accumulation of lipids in human cells]
Diabetes mellitus and atherosclerosis.
Prevention of experimental carotid artery thrombosis by magnetic vectoring of aspirin.
The gangliosides of adult human aorta: intima, media and plaque.
[Local prevention of thrombosis in the dog carotid artery using magnetically concentrated erythrocytes loaded with aspirin]
Association of low-density lipoprotein with particulate connective tissue matrix components enhances cholesterol accumulation in cultured subendothelial cells of human aorta.
Trapidil derivatives as potential antiatherosclerotic drugs.
Evidence of antiatherosclerotic action of verapamil from direct effects on arterial cells.
[Comparison of 2 methods of flow cytofluorometric analysis of epithelial cells in the diagnosis of uterine cervix cancer]
Comparative investigations of the reoccluded distal anastomosis, the spontaneous atherosclerotic plaque and the normal intima of the human femoral artery.
Disorders in the system of cyclic nucleotides in atherosclerosis: cyclic AMP and cyclic GMP content and activity of related enzymes in human aorta.
Is prostacyclin a major prostaglandin produced by endothelial cells in culture?
On the role of cyclic nucleotides in the pathogenesis of human atherosclerosis.
Low-density lipoprotein apheresis and regression of atherosclerotic plaque in vitro.
Intimal cells and atherosclerosis. Relationship between the number of intimal cells and major manifestations of atherosclerosis in the human aorta.
Effect of cyclic AMP on lipid accumulation and metabolism in human atherosclerotic aortic cells.
Atherogenicity of blood serum from patients with coronary heart disease.
Primary culture of human aortic intima cells as a model for testing antiatherosclerotic drugs. Effects of cyclic AMP, prostaglandins, calcium antagonists, antioxidants, and lipid-lowering agents.
Monoclonal antibody reveals heterogeneity in human aortic intima: detection of a ganglioside antigen associated with a subpopulation of intimal cells.
Adult human aortic cells in primary culture: heterogeneity in shape.
Cyclic AMP and cyclic GMP content in a short-term organ culture of normal and atherosclerotic human aorta.
[Concentration of erythrocyte-based magnetic carriers in the vascular bed]
Lipids in cells of atherosclerotic and uninvolved human aorta. II. Lipid metabolism in primary culture.
Determination of total intracellular lipid content by flow cytofluorometry.
LDL apheresis and regression of atherosclerosis.
Primary RIA screening of hybridoma supernatants without use of a negative control.
Lipids in cells of atherosclerotic and uninvolved human aorta. I. Lipid composition of aortic tissue and enzyme-isolated and cultured cells.
[Cellular composition and biochemical characteristics of the human aorta]
Artificial HDL as an anti-atherosclerotic drug.
Content and localization of fibronectin in normal intima, atherosclerotic plaque, and underlying media of human aorta.
Cellular composition of atherosclerotic and uninvolved human aortic subendothelial intima. Light-microscopic study of dissociated aortic cells.
[Immunomorphological study of fibronectin localization in a primary human aorta cell culture]
[Decrease in the lipid content of human atherosclerotic aorta cells as affected by compounds increasing the intracellular level of cyclic AMP]
[Determination of the lipid content of a single cell by flow cytofluorometry]
[Study of the structural and functional properties of fibronectin--a high molecular weight plasma glycoproteins--by using monoclonal antibodies]
Dissociated cells from different layers of adult human aortic wall.
Enzymatic detoxication of superoxide anion-radicals and lipoperoxides in intima and media of atherosclerotic aorta.
Heterogeneity of human aortic cells in regard to RNA content.
Primary cultures of enzyme-isolated cells from normal and atherosclerotic human aorta.
Regression of atherosclerotic manifestations in primary culture of human aortic cells: effects of prostaglandins.
[Immunomorphological study of the localization of types I, III, IV and V collagen in a primary culture of human aortic cells]
Prostacyclin analogues as antiatherosclerotic drugs.
[3H-thymidine incorporation into human aorta cells in primary culture. An autoradiographic study]
Cell proliferation in normal and atherosclerotic human aorta. II. Autoradiographic observation on deoxyribonucleic acid synthesis in primary cell culture.
[Effect of dibutyryl-cAMP on the cholesterol ester content in human atherosclerotic aorta cells]
Cell proliferation in normal and atherosclerotic human aorta. I. Flow cytofluorometric determination of cellular deoxyribonucleic acid content.
[Content of lipids in cells, isolated from normal and atherosclerotically-altered portions of the human aorta]
[Use of perilenoyl-labelled triglyceride as a fluorescent probe for staining lipid inclusions in cultured cells]
Stellate cells in the intima of human aorta. Application of alkaline dissociation method in the analysis of the vessel wall cellular content.
[Detection of 2 cell subpopulations each differing in incorporating low-density lipoproteins in an atherosclerotic plaque from the human aorta]
Dibutyryl cyclic AMP decreases proliferative activity and the cholesteryl ester content in cultured cells of atherosclerotic human aorta.
[Lipid metabolism in cells of human atherosclerotic aorta. Study in the primary culture]
[RNA content of cells isolated from normal and arteriosclerotic human aorta]
[Polymorphism of human aortic cells in culture]
[Post-radiation disorders in the cyclic AMP system of mouse spleen and thymus lymphoid cells]
[Effect of ionizing radiation on the activity of adenylate cyclase, cAMP phosphodiesterase and the level of cAMP in mouse liver]
[Effect of radiation-protective preparations on the level of cyclic adenosine-3',5'-monophosphate (cycl AMP), adenylate cyclase and cycl AMP phosphodiesterase]
[A method of determining adenylate cyclase activity]
[Role of endogenous substances in the creation of a background of increased radioresistance. Report 7. Study of the influence of dopamine and histamine on lipid radiosensitizers]
[Role of endogenic substances in creating a background of increased radioresistance. 3. The role of endogenic serotonin]
[Role of endogenous substances in developing a basis for increased radiation resistance. 4. Effect of serotonin on lipid radiation sensitizers]
METHOD FOR DETECTION OF PREDISPOSITION TO ATHEROSCLEROSIS, CORONARY HEART DISEASE AND RELATED CONDITIONS
METHOD FOR TREATING MASTOPATHY
Direct anti-atherosclerotic therapy preventing intracellular cholesterol retention: Health
Effects of garlic on atherosclerosis: Nutrition
In vitro models of antiatherosclerotic effects of cardiovascular drugs: The American Journal of Cardiology
Intracellular Cholesterol Retention—New Target for Direct Anti-Atherosclerotic Therapy: Open Journal of Endocrine and Metabolic Diseases
Vascular Extracellular Matrix in Atherosclerosis
Lipoprotein immune complexes and their role in atherogenesis
Adult human aortic cells in primary culture: heterogeneity in shape: Heart and Vessels
Subendothelial smooth muscle cells of human aorta express macrophage antigen in situ and in vitro: Atherosclerosis
Cell proliferation in normal and atherosclerotic human aorta: proliferative splash in lipid-rich lesions: Atherosclerosis
Primary RIA screening of hybridoma supernatants without use of a negative control: Journal of Immunological Methods
Desialylated low density lipoprotein - naturally occurring modified lipoprotein with atherogenic potency: Atherosclerosis
Anti-Atherosclerotic Therapy Based on Botanicals: Recent Patents on Cardiovascular Drug Discovery
Lack of correlation between degree of human plasma low density lipoprotein oxidation and its atherogenic potential: BioFactors
Direct Anti-atherosclerosis-related Effects of Garlic: Annals of Medicine
Characteristics of low-density lipoprotein subfractions from patients with coronary artery disease
Antiatherogenic and antiatherosclerotic effects of mushroom extracts revealed in human aortic intima cell culture: Drug Development Research
Beta-blockers: propranolol, metoprolol, atenolol, pindolol, alprenolol and timolol, manifest atherogenicity on in vitro, ex vivo and in vivo models. Elimination of propranolol atherogenic effects by papaverine: Atherosclerosis
Diagnostic value of immune cholesterol as a marker for atherosclerosis
Isolation of atherogenic modified (desialylated) low density lipoprotein from blood of atherosclerotic patients: Separation from native lipoprotein by affinity chromatography: Biochemical and Biophysical Research Communications
Effects of Calcium Antagonists, β-Blockers, and Nitrates on Atherosclerotic Characteristics of Human Aortic Cells: Journal of Cardiovascular Pharmacology
Correlation between cholesterol content in circulating immune complexes and atherogenic properties of CHD patients' serum manifested in cell culture: Atherosclerosis
Lipid-Lowering Effects of Time-Released Garlic Powder Tablets in Double-Blinded Placebo-Controlled Randomized Study: Journal of Atherosclerosis and Thrombosis
Antiatherosclerotic and antiatherogenic effects of a calcium antagonist plus statin combination: amlodipine and lovastatin: International Journal of Cardiology
Lipoprotein aggregation as an essential condition of intracellular lipid accumulation caused by modified low density lipoproteins: Biochemical and Biophysical Research Communications
The effects of time-released garlic powder tablets on multifunctional cardiovascular risk in patients with coronary artery disease: Lipids in Health and Disease
Deglycosilation is an atherogenic modification of apo-b-containing lipoproteins: Atherosclerosis
The reduction of estimated cardiovascular risk with Allicor: Atherosclerosis
Deglycosylation is an atherogenic modification of ApoB-containing lipoproteins: Atherosclerosis